Form 8-K · Item 4.01 · Auditor change
Benitec Biopharma Inc.: auditor change, Ernst & Young LLP engaged
Benitec Biopharma Inc. reported in a Form 8-K filed September 30, 2026, that on September 29, 2026, Ernst & Young LLP was engaged.
In the filing's words
the Company reported the approval of the engagement of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027.
On September 29, 2026, the Company and EY executed an engagement letter to engage EY as the Company’s independent registered public accounting firm.
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | Benitec Biopharma Inc. |
|---|---|
| Ticker | BNTC |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | September 30, 2026 |
| What the filing states | engaged |
| Former accountant | Not established by the filing |
| New accountant | Ernst & Young LLP |
| Date of the change | September 29, 2026 |
| Disagreements | not stated |
| Accession number | 0001193125-26-409052 |
| SEC CIK | 0001808898 |
Benitec Biopharma Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed September 30, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Form 8-K, Item 4.01 · accessed 2026-10-23
Documented unknowns
- former_auditor: The filing does not name the former auditor.
More: all auditor changes · Something wrong? Send a correction with the primary source.